Genomic architecture of sickle cell disease in West African children

Jacklyn Quinlan, Youssef Idaghdhour, Jean Philippe Goulet, Elias Gbeha, Thibault de Malliard, Vanessa Bruat, Jean Christophe Grenier, Selma Gomez, Ambaliou Sanni, Mohamed C. Rahimy, Philip Awadalla

Research output: Contribution to journalArticle

Abstract

Sickle cell disease (SCD) is a congenital blood disease, affecting predominantly children from sub-Saharan Africa, but also populations world-wide. Although the causal mutation of SCD is known, the sources of clinical variability of SCD remain poorly understood, with only a few highly heritable traits associated with SCD having been identified. Phenotypic heterogeneity in the clinical expression of SCD is problematic for follow-up (FU), management, and treatment of patients. Here we used the joint analysis of gene expression and whole genome genotyping data to identify the genetic regulatory effects contributing to gene expression variation among groups of patients exhibiting clinical variability, as well as unaffected siblings, in Benin, West Africa. We characterized and replicated patterns of whole blood gene expression variation within and between SCD patients at entry to clinic, as well as in follow-up programs. We present a global map of genes involved in the disease through analysis of whole blood sampled from the cohort. Genome-wide association mapping of gene expression revealed 390 peak genome-wide significant expression SNPs (eSNPs) and 6 significant eSNP-by-clinical status interaction effects. The strong modulation of the transcriptome implicates pathways affecting core circulating cell functions and shows how genotypic regulatory variation likely contributes to the clinical variation observed in SCD.

Original languageEnglish (US)
Article numberArticle 26
JournalFrontiers in Genetics
Volume5
Issue numberFEB
DOIs
StatePublished - Jan 1 2014

Fingerprint

Sickle Cell Anemia
Gene Expression
Genome
Single Nucleotide Polymorphism
Benin
Western Africa
Hematologic Diseases
Africa South of the Sahara
Transcriptome
Siblings
Mutation
Population
Genes

Keywords

  • ESNP mapping
  • Gene-by-environment interactions
  • Genomics
  • Sickle cell disease
  • Transcriptome

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Genetics(clinical)

Cite this

Quinlan, J., Idaghdhour, Y., Goulet, J. P., Gbeha, E., de Malliard, T., Bruat, V., ... Awadalla, P. (2014). Genomic architecture of sickle cell disease in West African children. Frontiers in Genetics, 5(FEB), [Article 26]. https://doi.org/10.3389/fgene.2014.00026

Genomic architecture of sickle cell disease in West African children. / Quinlan, Jacklyn; Idaghdhour, Youssef; Goulet, Jean Philippe; Gbeha, Elias; de Malliard, Thibault; Bruat, Vanessa; Grenier, Jean Christophe; Gomez, Selma; Sanni, Ambaliou; Rahimy, Mohamed C.; Awadalla, Philip.

In: Frontiers in Genetics, Vol. 5, No. FEB, Article 26, 01.01.2014.

Research output: Contribution to journalArticle

Quinlan, J, Idaghdhour, Y, Goulet, JP, Gbeha, E, de Malliard, T, Bruat, V, Grenier, JC, Gomez, S, Sanni, A, Rahimy, MC & Awadalla, P 2014, 'Genomic architecture of sickle cell disease in West African children', Frontiers in Genetics, vol. 5, no. FEB, Article 26. https://doi.org/10.3389/fgene.2014.00026
Quinlan J, Idaghdhour Y, Goulet JP, Gbeha E, de Malliard T, Bruat V et al. Genomic architecture of sickle cell disease in West African children. Frontiers in Genetics. 2014 Jan 1;5(FEB). Article 26. https://doi.org/10.3389/fgene.2014.00026
Quinlan, Jacklyn ; Idaghdhour, Youssef ; Goulet, Jean Philippe ; Gbeha, Elias ; de Malliard, Thibault ; Bruat, Vanessa ; Grenier, Jean Christophe ; Gomez, Selma ; Sanni, Ambaliou ; Rahimy, Mohamed C. ; Awadalla, Philip. / Genomic architecture of sickle cell disease in West African children. In: Frontiers in Genetics. 2014 ; Vol. 5, No. FEB.
@article{15d563424a9f474c9db9d0ccfe7bcf25,
title = "Genomic architecture of sickle cell disease in West African children",
abstract = "Sickle cell disease (SCD) is a congenital blood disease, affecting predominantly children from sub-Saharan Africa, but also populations world-wide. Although the causal mutation of SCD is known, the sources of clinical variability of SCD remain poorly understood, with only a few highly heritable traits associated with SCD having been identified. Phenotypic heterogeneity in the clinical expression of SCD is problematic for follow-up (FU), management, and treatment of patients. Here we used the joint analysis of gene expression and whole genome genotyping data to identify the genetic regulatory effects contributing to gene expression variation among groups of patients exhibiting clinical variability, as well as unaffected siblings, in Benin, West Africa. We characterized and replicated patterns of whole blood gene expression variation within and between SCD patients at entry to clinic, as well as in follow-up programs. We present a global map of genes involved in the disease through analysis of whole blood sampled from the cohort. Genome-wide association mapping of gene expression revealed 390 peak genome-wide significant expression SNPs (eSNPs) and 6 significant eSNP-by-clinical status interaction effects. The strong modulation of the transcriptome implicates pathways affecting core circulating cell functions and shows how genotypic regulatory variation likely contributes to the clinical variation observed in SCD.",
keywords = "ESNP mapping, Gene-by-environment interactions, Genomics, Sickle cell disease, Transcriptome",
author = "Jacklyn Quinlan and Youssef Idaghdhour and Goulet, {Jean Philippe} and Elias Gbeha and {de Malliard}, Thibault and Vanessa Bruat and Grenier, {Jean Christophe} and Selma Gomez and Ambaliou Sanni and Rahimy, {Mohamed C.} and Philip Awadalla",
year = "2014",
month = "1",
day = "1",
doi = "10.3389/fgene.2014.00026",
language = "English (US)",
volume = "5",
journal = "Frontiers in Genetics",
issn = "1664-8021",
publisher = "Frontiers Media S. A.",
number = "FEB",

}

TY - JOUR

T1 - Genomic architecture of sickle cell disease in West African children

AU - Quinlan, Jacklyn

AU - Idaghdhour, Youssef

AU - Goulet, Jean Philippe

AU - Gbeha, Elias

AU - de Malliard, Thibault

AU - Bruat, Vanessa

AU - Grenier, Jean Christophe

AU - Gomez, Selma

AU - Sanni, Ambaliou

AU - Rahimy, Mohamed C.

AU - Awadalla, Philip

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Sickle cell disease (SCD) is a congenital blood disease, affecting predominantly children from sub-Saharan Africa, but also populations world-wide. Although the causal mutation of SCD is known, the sources of clinical variability of SCD remain poorly understood, with only a few highly heritable traits associated with SCD having been identified. Phenotypic heterogeneity in the clinical expression of SCD is problematic for follow-up (FU), management, and treatment of patients. Here we used the joint analysis of gene expression and whole genome genotyping data to identify the genetic regulatory effects contributing to gene expression variation among groups of patients exhibiting clinical variability, as well as unaffected siblings, in Benin, West Africa. We characterized and replicated patterns of whole blood gene expression variation within and between SCD patients at entry to clinic, as well as in follow-up programs. We present a global map of genes involved in the disease through analysis of whole blood sampled from the cohort. Genome-wide association mapping of gene expression revealed 390 peak genome-wide significant expression SNPs (eSNPs) and 6 significant eSNP-by-clinical status interaction effects. The strong modulation of the transcriptome implicates pathways affecting core circulating cell functions and shows how genotypic regulatory variation likely contributes to the clinical variation observed in SCD.

AB - Sickle cell disease (SCD) is a congenital blood disease, affecting predominantly children from sub-Saharan Africa, but also populations world-wide. Although the causal mutation of SCD is known, the sources of clinical variability of SCD remain poorly understood, with only a few highly heritable traits associated with SCD having been identified. Phenotypic heterogeneity in the clinical expression of SCD is problematic for follow-up (FU), management, and treatment of patients. Here we used the joint analysis of gene expression and whole genome genotyping data to identify the genetic regulatory effects contributing to gene expression variation among groups of patients exhibiting clinical variability, as well as unaffected siblings, in Benin, West Africa. We characterized and replicated patterns of whole blood gene expression variation within and between SCD patients at entry to clinic, as well as in follow-up programs. We present a global map of genes involved in the disease through analysis of whole blood sampled from the cohort. Genome-wide association mapping of gene expression revealed 390 peak genome-wide significant expression SNPs (eSNPs) and 6 significant eSNP-by-clinical status interaction effects. The strong modulation of the transcriptome implicates pathways affecting core circulating cell functions and shows how genotypic regulatory variation likely contributes to the clinical variation observed in SCD.

KW - ESNP mapping

KW - Gene-by-environment interactions

KW - Genomics

KW - Sickle cell disease

KW - Transcriptome

UR - http://www.scopus.com/inward/record.url?scp=84897716074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897716074&partnerID=8YFLogxK

U2 - 10.3389/fgene.2014.00026

DO - 10.3389/fgene.2014.00026

M3 - Article

VL - 5

JO - Frontiers in Genetics

JF - Frontiers in Genetics

SN - 1664-8021

IS - FEB

M1 - Article 26

ER -